Ginsenoside Rg5 as an anticancer drug: a comprehensive review on mechanisms, structure–activity relationship, and prospects for clinical advancement
Authors:
- Tilal ElsamanTETilal Elsaman
- Ali Mahmoud MuddathirAMAli Mahmoud Muddathir
- Ebtihal A. M. MohieldinEMEbtihal A. M. Mohieldin
- Irmanida BatubaraIBIrmanida Batubara
- Min RahminiwatiMRMin Rahminiwati
- Kosei YamauchiKYKosei Yamauchi
- Magdi Awadalla MohamedMMMagdi Awadalla Mohamed
- Shadila Fira AsokaShadila Fira Asoka
- Dietrich BüsselbergDietrich Büsselberg
- Solomon HabtemariamSolomon Habtemariam
- Javad Sharifi-RadJavad Sharifi-Rad
- 25 March 2024
- journal article
- review article
- Published by Springer Nature in Pharmacological Reports
- Vol. 76 (2) , 287-306
Abstract
Cancer remains one of the leading causes of death in the world. Despite the considerable success of conventional treatment strategies, the incidence and mortality rates are still high, making developing new effective anticancer therapies an urgent priority. Ginsenoside Rg5 (Rg5) is a minor ginsenoside constituent obtained exclusively from ginseng species and is known for its broad spectrum of pharmacological activities. This article aimed to comprehensively review the anticancer properties of Rg5, focusing on action mechanisms, structure–activity relationship (SAR), and pharmacokinetics attributes. The in vitro and in vivo activities of Rg5 have been proven against several cancer types, such as breast, liver, lung, bone, and gastrointestinal (GI) cancers. The modulation of multiple signaling pathways critical for cancer growth and survival mediates these activities. Nevertheless, human clinical studies of Rg5 have not been addressed before, and there is still considerable ambiguity regarding its pharmacokinetics properties. In addition, a significant shortage in the structure–activity relationship (SAR) of Rg5 has been identified. Therefore, future efforts should focus on further optimization by performing extensive SAR studies to uncover the structural features essential for the potent anticancer activity of Rg5. Thus, this review highlights the value of Rg5 as a potential anticancer drug candidate and identifies the research areas requiring more investigation.Keywords
This publication has 115 references indexed in Scilit:
- Anti-viral triterpenes: a reviewPhytochemistry Reviews, 2022
- OsteosarcomaPediatric Blood & Cancer, 2020
- Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non–Small Cell Lung CancerJAMA Network Open, 2019
- Natural Bio-active Compounds2019
- Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancerCancer Causes & Control, 2015
- Preparation of ginsenosides Rg3, Rk1, and Rg5-selectively enriched ginsengs by a simple steaming processEuropean Food Research and Technology, 2014
- EXPRESSION OF CONCERN: Ginsenosides protect striatal neurons in a cellular model of Huntington's diseaseJournal of Neuroscience Research, 2009
- Anti-androgen-independent prostate cancer effects of ginsenoside metabolites In Vitro: Mechanism and possible structure-activity relationship investigationArchives of Pharmacal Research, 2009
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Ginsenoside Rg5, a genuine dammarane glycoside from Korean red ginsengArchives of Pharmacal Research, 1996